Close
Back to EDIT Stock Lookup

Editas Medicine (EDIT) – Litigation

Feb 28, 2022 04:04 PM Editas Medicine (EDIT) Announces Favorable Decision from U.S. Patent and Trademark Office in CRISPR Patent Interference
Sep 11, 2020 07:05 AM Editas Medicine (EDIT) Announces U.S. Patent and Trademark Office Grants the Broad Institute Priority Benefit in CRISPR Interference
Sep 10, 2018 01:59 PM
Sep 10, 2018 10:33 AM
Feb 15, 2017 01:59 PM
Feb 15, 2017 12:49 PM

Back to EDIT Stock Lookup